FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616915637> ?p ?o ?g. }

• W2616915637 endingPage "190" @default.
• W2616915637 startingPage "184" @default.
• W2616915637 abstract "Background: A single, effective therapeutic regimen for keloids has not been established yet, and the development of novel therapeutic approaches is expected. Butyrate, a short-chain fatty acid, and docosahexaenoic acid (DHA), a ω-3 polyunsaturated fatty acid, play multiple anti-inflammatory and anticancer roles via their respective mechanisms of action. Objective: In this study, we evaluated the antifibrogenic effects of their single and combined use on keloid fibroblasts. Methods: Keloid fibroblasts were treated with butyrate (0-16 mM) and/or DHA (0-100 µM) for 48 or 96 h. Results: Butyrate inhibited cell proliferation, and α-smooth muscle actin (α-SMA) and type III collagen expressions, with inhibition of the transforming growth factor (TGF)-β1 and TGF-β type I receptor expressions and increased prostaglandin E2 with upregulation of cyclooxygenase-1 expression with induction of histone acetylation. DHA inhibited α-SMA, type III collagen, and TGF-β type I receptor expressions. Then, the butyrate/DHA combination augmented the antifibrogenic effects, resulting in additional inhibition of α-SMA, type I and III collagen expressions, with strong disruption of stress fiber and apoptosis induction. Moreover, the butyrate/DHA combination inhibited the cyclooxygenase-2 expression, suggesting stronger anti-inflammatory effect than each monotherapy. Study limitations: Activation in keloid tissue is affected not only by fibroblasts but also by epithelial cells and immune cells. Evaluation of the effects by butyrate and DHA in these cells or in an in vivo study is required. Conclusion: This study demonstrated that butyrate and docosahexaenoic acid have antifibrogenic effects on keloid fibroblasts and that these may exert therapeutic effects for keloid." @default.
• W2616915637 created "2017-06-05" @default.
• W2616915637 creator A5015325102 @default.
• W2616915637 creator A5019243796 @default.
• W2616915637 creator A5035049755 @default.
• W2616915637 creator A5046131973 @default.
• W2616915637 creator A5064304187 @default.
• W2616915637 creator A5087291804 @default.
• W2616915637 date "2017-03-01" @default.
• W2616915637 modified "2023-10-13" @default.
• W2616915637 title "Combination therapy with butyrate and docosahexaenoic acid for keloid fibrogenesis: an in vitro study" @default.
• W2616915637 cites W1510316918 @default.
• W2616915637 cites W1513168953 @default.
• W2616915637 cites W1722767644 @default.
• W2616915637 cites W1964095936 @default.
• W2616915637 cites W1966760994 @default.
• W2616915637 cites W1970779494 @default.
• W2616915637 cites W1972982814 @default.
• W2616915637 cites W1975516847 @default.
• W2616915637 cites W1976141939 @default.
• W2616915637 cites W1981768058 @default.
• W2616915637 cites W1989386822 @default.
• W2616915637 cites W2002959213 @default.
• W2616915637 cites W2006937273 @default.
• W2616915637 cites W2007479878 @default.
• W2616915637 cites W2016193552 @default.
• W2616915637 cites W2016859944 @default.
• W2616915637 cites W2025153976 @default.
• W2616915637 cites W2032910462 @default.
• W2616915637 cites W2036838886 @default.
• W2616915637 cites W2055662034 @default.
• W2616915637 cites W2057717947 @default.
• W2616915637 cites W2072716831 @default.
• W2616915637 cites W2079536723 @default.
• W2616915637 cites W2080293966 @default.
• W2616915637 cites W2082579037 @default.
• W2616915637 cites W2083940160 @default.
• W2616915637 cites W2087065720 @default.
• W2616915637 cites W2088853187 @default.
• W2616915637 cites W2092557137 @default.
• W2616915637 cites W2095056036 @default.
• W2616915637 cites W2106379906 @default.
• W2616915637 cites W2111733995 @default.
• W2616915637 cites W2115604279 @default.
• W2616915637 cites W2117536783 @default.
• W2616915637 cites W2130654131 @default.
• W2616915637 cites W2132237098 @default.
• W2616915637 cites W2132288432 @default.
• W2616915637 cites W2140937256 @default.
• W2616915637 cites W2170348331 @default.
• W2616915637 cites W2173983331 @default.
• W2616915637 doi "https://doi.org/10.1590/abd1806-4841.20176198" @default.
• W2616915637 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5429102" @default.
• W2616915637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28538876" @default.
• W2616915637 hasPublicationYear "2017" @default.
• W2616915637 type Work @default.
• W2616915637 sameAs 2616915637 @default.
• W2616915637 citedByCount "12" @default.
• W2616915637 countsByYear W26169156372017 @default.
• W2616915637 countsByYear W26169156372018 @default.
• W2616915637 countsByYear W26169156372019 @default.
• W2616915637 countsByYear W26169156372020 @default.
• W2616915637 countsByYear W26169156372022 @default.
• W2616915637 countsByYear W26169156372023 @default.
• W2616915637 crossrefType "journal-article" @default.
• W2616915637 hasAuthorship W2616915637A5015325102 @default.
• W2616915637 hasAuthorship W2616915637A5019243796 @default.
• W2616915637 hasAuthorship W2616915637A5035049755 @default.
• W2616915637 hasAuthorship W2616915637A5046131973 @default.
• W2616915637 hasAuthorship W2616915637A5064304187 @default.
• W2616915637 hasAuthorship W2616915637A5087291804 @default.
• W2616915637 hasBestOaLocation W26169156371 @default.
• W2616915637 hasConcept C100544194 @default.
• W2616915637 hasConcept C118131993 @default.
• W2616915637 hasConcept C134018914 @default.
• W2616915637 hasConcept C142724271 @default.
• W2616915637 hasConcept C185592680 @default.
• W2616915637 hasConcept C19038510 @default.
• W2616915637 hasConcept C2776979534 @default.
• W2616915637 hasConcept C2777171753 @default.
• W2616915637 hasConcept C2777538232 @default.
• W2616915637 hasConcept C502942594 @default.
• W2616915637 hasConcept C543025807 @default.
• W2616915637 hasConcept C55493867 @default.
• W2616915637 hasConcept C71924100 @default.
• W2616915637 hasConcept C98274493 @default.
• W2616915637 hasConceptScore W2616915637C100544194 @default.
• W2616915637 hasConceptScore W2616915637C118131993 @default.
• W2616915637 hasConceptScore W2616915637C134018914 @default.
• W2616915637 hasConceptScore W2616915637C142724271 @default.
• W2616915637 hasConceptScore W2616915637C185592680 @default.
• W2616915637 hasConceptScore W2616915637C19038510 @default.
• W2616915637 hasConceptScore W2616915637C2776979534 @default.
• W2616915637 hasConceptScore W2616915637C2777171753 @default.
• W2616915637 hasConceptScore W2616915637C2777538232 @default.
• W2616915637 hasConceptScore W2616915637C502942594 @default.
• W2616915637 hasConceptScore W2616915637C543025807 @default.
• W2616915637 hasConceptScore W2616915637C55493867 @default.

• next